Total Payments
$1,233
2024 Payments
$39.47
Companies
12
Transactions
63
Medicare Patients
533
Medicare Billing
$52,039
Payment Breakdown by Category
Food & Beverage$1,233 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,233 | 63 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $330.49 | 26 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $282.68 | 14 | $0 (2023) |
| Axsome Therapeutics, Inc. | $139.24 | 3 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $134.12 | 2 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $84.35 | 4 | $0 (2023) |
| UROVANT SCIENCES INC | $79.17 | 5 | $0 (2022) |
| Alkermes, Inc. | $68.60 | 3 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $45.36 | 2 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $21.99 | 1 | $0 (2023) |
| Lundbeck LLC | $19.44 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39.47 | 2 | Otsuka America Pharmaceutical, Inc. ($25.07) |
| 2023 | $1,114 | 56 | ABBVIE INC. ($316.09) |
| 2022 | $79.17 | 5 | UROVANT SCIENCES INC ($79.17) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: NEUROLOGY | ||||||
| 08/14/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: CNS | ||||||
| 07/27/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.44 | General |
| Category: PSYCHIATRY | ||||||
| 07/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Central Nervous System | ||||||
| 07/26/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Central Nervous System | ||||||
| 07/26/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: PSYCHOLOGY | ||||||
| 07/13/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Neuropsychiatry | ||||||
| 07/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.66 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: CNS | ||||||
| 06/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: NEUROSCIENCE | ||||||
| 06/16/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Central Nervous System | ||||||
| 06/15/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Central Nervous System | ||||||
| 06/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $119.34 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/08/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 06/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $99.98 | General |
| Category: Central Nervous System | ||||||
| 06/06/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Central Nervous System | ||||||
| 06/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $4.78 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/25/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 05/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 228 | 388 | $54,100 | $22,576 |
| 2022 | 11 | 305 | 549 | $76,915 | $29,463 |
Total Patients
533
Total Services
937
Medicare Billing
$52,039
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 85 | 181 | $26,330 | $12,124 | 46.0% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 42 | 53 | $11,310 | $5,028 | 44.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 23 | 32 | $3,520 | $1,334 | 37.9% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 14 | 14 | $2,380 | $1,178 | 49.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 22 | 32 | $4,800 | $1,029 | 21.4% |
| G0317 | Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualifi | Facility | 2023 | 17 | 51 | $2,295 | $998.75 | 43.5% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 13 | 13 | $2,145 | $634.70 | 29.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 12 | 12 | $1,320 | $250.77 | 19.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 54 | 122 | $18,300 | $7,174 | 39.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 47 | 124 | $13,640 | $5,534 | 40.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 30 | 87 | $9,570 | $3,883 | 40.6% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 17 | 17 | $6,800 | $3,097 | 45.5% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 19 | 25 | $4,250 | $2,168 | 51.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 20 | 30 | $4,500 | $1,764 | 39.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 15 | 15 | $4,500 | $1,603 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 18 | $4,086 | $1,292 | 31.6% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 16 | 19 | $3,800 | $963.49 | 25.4% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 21 | 32 | $2,720 | $905.28 | 33.3% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 13 | 21 | $1,785 | $594.09 | 33.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 11 | $1,650 | $298.26 | 18.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 13 | 13 | $1,209 | $142.56 | 11.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 14 | 15 | $105.00 | $44.88 | 42.7% |
About Jody Madden, CRNP
Jody Madden, CRNP is a Psychiatric/Mental Health healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2014. The National Provider Identifier (NPI) number assigned to this provider is 1023421344.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jody Madden, CRNP has received a total of $1,233 in payments from pharmaceutical and medical device companies, with $39.47 received in 2024. These payments were reported across 63 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,233).
As a Medicare-enrolled provider, Madden has provided services to 533 Medicare beneficiaries, totaling 937 services with total Medicare billing of $52,039. Data is available for 2 years (2022–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Adult Health
- Location Pittsburgh, PA
- Active Since 06/04/2014
- Last Updated 11/04/2024
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1023421344
Products in Payments
- VRAYLAR (Drug) $330.49
- Austedo XR (Drug) $191.08
- Auvelity (Drug) $139.24
- INGREZZA (Drug) $134.12
- GEMTESA (Drug) $101.16
- AUSTEDO (Drug) $91.60
- HETLIOZ (Drug) $84.35
- ARISTADA (Drug) $68.60
- REXULTI (Drug) $39.73
- NUEDEXTA (Drug) $25.07
- QELBREE (Drug) $13.99
- SPRAVATO (Drug) $13.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Pittsburgh
Britney Scolieri, Dnp, Pmhnp-Bc, DNP, PMHNP-BC
Psychiatric/Mental Health — Payments: $112,057
Psychiatric/Mental Health $112,057
Ashley Wood, Crnp Pmhnp, CRNP PMHNP
Psychiatric/Mental Health — Payments: $4,796
Psychiatric/Mental Health $4,796
Dr. Joshua Palmer, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $4,230
Psychiatric/Mental Health $4,230
Dr. Danielle Dipre, Phmnp-Bc Dnp, PHMNP-BC DNP
Psychiatric/Mental Health — Payments: $1,864
Psychiatric/Mental Health $1,864
Dr. Brad Burns, Dnp, Pmhnp-Bc, DNP, PMHNP-BC
Psychiatric/Mental Health — Payments: $1,848
Psychiatric/Mental Health $1,848
Jerrod Nestor
Psychiatric/Mental Health — Payments: $1,771
Psychiatric/Mental Health $1,771